photo of

Details

Role Group Leader / Honorary Fellow Manager
Research area Infection, Immunity and Global Health
Group Molecular Microbiology
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.

Top Publications

  • Chow, EPF, Tabrizi, SN, Fairley, CK, Wigan, R, Machalek, DA, Garland, SM, Cornall, AM, Atchison, S, Hocking, JS, Bradshaw, CS, et al. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study. The Lancet Infectious Diseases 21(10) : 1448 -1457 2021
    view publication
  • Chua, T-P, Bodiyabadu, K, Machalek, DA, Garland, SM, Bradshaw, CS, Plummer, EL, Danielewski, J, Vodstrcil, LA, Doyle, ML, Murray, GL. Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men. Journal of Medical Microbiology 70(9) : 001429 2021
    view publication
  • Plummer, EL, Vodstrcil, LA, Bodiyabadu, K, Murray, GL, Doyle, M, Latimer, RL, Fairley, CK, Payne, M, Chow, EPF, Garland, SM, et al. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum associated with specific genital symptoms and clinical signs in non-pregnant women?. Clinical Infectious Diseases 73(4) : ciab061- 2021
    view publication
  • Plummer, EL, Danielewski, JA, Garland, SM, Su, J, Jacobs, SE, Murray, GL. The effect of probiotic supplementation on the gut microbiota of preterm infants. Journal of Medical Microbiology 70(8) : 001403 2021
    view publication
  • Shilling, H, Garland, SM, Atchison, S, Cornall, AM, Brotherton, JML, Bateson, D, McNamee, K, Kaldor, JM, Hocking, JS, Chen, MY, et al. Human papillomavirus prevalence and risk factors among Australian women 9–12 years after vaccine program introduction. Vaccine 39(34) : 4856 -4863 2021
    view publication

Page 18 of 147

Related links